Survodutide 10 mg

Buy Stealth Labs Survodutide 10 mg – Dual GLP-1 and Glucagon Receptor Peptide

Stealth Labs Survodutide 10 mg is a next-generation investigational peptide developed to target both GLP-1 and glucagon receptors for amplified weight loss, appetite suppression, and improved metabolic regulation. Originally developed by Boehringer Ingelheim for obesity and NAFLD (non-alcoholic fatty liver disease) studies, Survodutide has shown promising fat-burning potential by combining appetite reduction with enhanced energy expenditure.

Lab-Tested for Clinical-Grade Purity

Each vial of Survodutide from Stealth Labs contains 10 mg of lyophilized peptide, tested on 2024-09-13 and verified to be ≥99.7% pure. Manufactured in sterile GMP-compliant conditions, this compound is ideal for advanced metabolic research applications.

Mechanism of Action

Survodutide is a dual agonist that binds to both the GLP-1 receptor (enhancing insulin secretion and reducing hunger) and the glucagon receptor (stimulating thermogenesis and fat oxidation). This dual pathway results in reduced food intake and increased calorie burn. A recent clinical trial demonstrated that Survodutide produced up to 18.7% weight loss in obese participants without diabetes—comparable to leading GLP-1 analogs.

Suggested Dosage & Administration

Survodutide is typically administered via subcutaneous injection once weekly. Research protocols often begin with 2.4 mg per week, titrating up to 6 mg per week depending on tolerance and study design. Reconstitute each vial with bacteriostatic water and refrigerate after mixing. Each 10 mg vial yields 1–4 doses depending on the selected dosing regimen.

Stacking Recommendations

Survodutide is often studied alongside additional metabolic regulators. For example, stacking with Melanotan 2 may help reduce appetite and improve skin tone during calorie deficits. For enhanced gut health or insulin sensitivity, pair with Thymosin Beta-4. Recovery peptides like BPC-157 may help offset training fatigue during aggressive weight-loss phases.

Why Researchers Choose Stealth Labs

Stealth Labs provides lab-tested, high-purity research peptides with full COA transparency. All peptides are lyophilized and vacuum-sealed for stability. For those pursuing cutting-edge studies in obesity, fatty liver disease, or GLP-1 innovation, this dual-receptor peptide formulation is one of the most promising new tools in metabolic science.

Explore Related Peptides

For additional fat-loss and appetite-modulating compounds, visit our full Stealth Labs peptide catalog. We offer research-grade formulations including semaglutide, cagrilintide, and tirzepatide.

Frequently Asked Questions